A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion

Maurizio Zibetti, Alberto Romagnolo, Aristide Merola, Lorenzo Priano, Elisa Montanaro, Serena Angrisano, Antonella Tribolo, Alessandro Cicolin, Leonardo Lopiano

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Sleep disorders are very common in advanced Parkinson’s disease (PD) and have a significant negative impact on the quality of life of patients. Questionnaire-based studies suggest that sleep quality might improve following levodopa–carbidopa intestinal gel (LCIG) infusion. The objective of this study was to evaluate the impact of LCIG infusion and subsequent oral medication changes on polysomnography (PSG) and sleep symptoms in advanced PD patients. Eleven PD patients underwent PSG at baseline and after 3.8 ± 1.2 months of LCIG treatment. LCIG infusion therapy was halted during PSG. Patients were assessed with the Unified-PD-rating-Scale and completed the PD-Sleep-Scale-version-2 (PDSS-2), the Epworth Sleepiness Scale and the RBD single question. Subjective sleep quality improved in all patients. PSG showed a reduction of the number of awakenings in sleep, a trend towards a lower apnea–hypopnea index and no change in sleep latency, total sleep time and sleep efficiency. There was a positive correlation between the number of awakenings and PDSS-2 scores for “difficulty staying asleep”, “muscle cramps of arms or legs” and “urge to move arms or legs”. Motor complications and activities of daily living improved with LCIG. Subjective sleep quality improved significantly and the PSG study showed a less fragmented sleep pattern in advanced PD patients treated with LCIG infusion.

Original languageEnglish
Pages (from-to)1085-1090
Number of pages6
JournalJournal of Neurology
Volume264
Issue number6
DOIs
Publication statusPublished - Jun 1 2017

Fingerprint

Levodopa
Sleep
Polysomnography
Parkinson Disease
Gels
Leg
Arm
Muscle Cramp
Activities of Daily Living
Motor Activity
Quality of Life

Keywords

  • Excessive daytime sleepiness
  • Levodopa–carbidopa intestinal gel infusion
  • Parkinson’s disease
  • Polysomnography
  • Sleep disorders

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Zibetti, M., Romagnolo, A., Merola, A., Priano, L., Montanaro, E., Angrisano, S., ... Lopiano, L. (2017). A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion. Journal of Neurology, 264(6), 1085-1090. https://doi.org/10.1007/s00415-017-8491-2

A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion. / Zibetti, Maurizio; Romagnolo, Alberto; Merola, Aristide; Priano, Lorenzo; Montanaro, Elisa; Angrisano, Serena; Tribolo, Antonella; Cicolin, Alessandro; Lopiano, Leonardo.

In: Journal of Neurology, Vol. 264, No. 6, 01.06.2017, p. 1085-1090.

Research output: Contribution to journalArticle

Zibetti, M, Romagnolo, A, Merola, A, Priano, L, Montanaro, E, Angrisano, S, Tribolo, A, Cicolin, A & Lopiano, L 2017, 'A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion', Journal of Neurology, vol. 264, no. 6, pp. 1085-1090. https://doi.org/10.1007/s00415-017-8491-2
Zibetti, Maurizio ; Romagnolo, Alberto ; Merola, Aristide ; Priano, Lorenzo ; Montanaro, Elisa ; Angrisano, Serena ; Tribolo, Antonella ; Cicolin, Alessandro ; Lopiano, Leonardo. / A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion. In: Journal of Neurology. 2017 ; Vol. 264, No. 6. pp. 1085-1090.
@article{d090efbda59549858ef7db192f3e28ab,
title = "A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion",
abstract = "Sleep disorders are very common in advanced Parkinson’s disease (PD) and have a significant negative impact on the quality of life of patients. Questionnaire-based studies suggest that sleep quality might improve following levodopa–carbidopa intestinal gel (LCIG) infusion. The objective of this study was to evaluate the impact of LCIG infusion and subsequent oral medication changes on polysomnography (PSG) and sleep symptoms in advanced PD patients. Eleven PD patients underwent PSG at baseline and after 3.8 ± 1.2 months of LCIG treatment. LCIG infusion therapy was halted during PSG. Patients were assessed with the Unified-PD-rating-Scale and completed the PD-Sleep-Scale-version-2 (PDSS-2), the Epworth Sleepiness Scale and the RBD single question. Subjective sleep quality improved in all patients. PSG showed a reduction of the number of awakenings in sleep, a trend towards a lower apnea–hypopnea index and no change in sleep latency, total sleep time and sleep efficiency. There was a positive correlation between the number of awakenings and PDSS-2 scores for “difficulty staying asleep”, “muscle cramps of arms or legs” and “urge to move arms or legs”. Motor complications and activities of daily living improved with LCIG. Subjective sleep quality improved significantly and the PSG study showed a less fragmented sleep pattern in advanced PD patients treated with LCIG infusion.",
keywords = "Excessive daytime sleepiness, Levodopa–carbidopa intestinal gel infusion, Parkinson’s disease, Polysomnography, Sleep disorders",
author = "Maurizio Zibetti and Alberto Romagnolo and Aristide Merola and Lorenzo Priano and Elisa Montanaro and Serena Angrisano and Antonella Tribolo and Alessandro Cicolin and Leonardo Lopiano",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/s00415-017-8491-2",
language = "English",
volume = "264",
pages = "1085--1090",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "6",

}

TY - JOUR

T1 - A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion

AU - Zibetti, Maurizio

AU - Romagnolo, Alberto

AU - Merola, Aristide

AU - Priano, Lorenzo

AU - Montanaro, Elisa

AU - Angrisano, Serena

AU - Tribolo, Antonella

AU - Cicolin, Alessandro

AU - Lopiano, Leonardo

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Sleep disorders are very common in advanced Parkinson’s disease (PD) and have a significant negative impact on the quality of life of patients. Questionnaire-based studies suggest that sleep quality might improve following levodopa–carbidopa intestinal gel (LCIG) infusion. The objective of this study was to evaluate the impact of LCIG infusion and subsequent oral medication changes on polysomnography (PSG) and sleep symptoms in advanced PD patients. Eleven PD patients underwent PSG at baseline and after 3.8 ± 1.2 months of LCIG treatment. LCIG infusion therapy was halted during PSG. Patients were assessed with the Unified-PD-rating-Scale and completed the PD-Sleep-Scale-version-2 (PDSS-2), the Epworth Sleepiness Scale and the RBD single question. Subjective sleep quality improved in all patients. PSG showed a reduction of the number of awakenings in sleep, a trend towards a lower apnea–hypopnea index and no change in sleep latency, total sleep time and sleep efficiency. There was a positive correlation between the number of awakenings and PDSS-2 scores for “difficulty staying asleep”, “muscle cramps of arms or legs” and “urge to move arms or legs”. Motor complications and activities of daily living improved with LCIG. Subjective sleep quality improved significantly and the PSG study showed a less fragmented sleep pattern in advanced PD patients treated with LCIG infusion.

AB - Sleep disorders are very common in advanced Parkinson’s disease (PD) and have a significant negative impact on the quality of life of patients. Questionnaire-based studies suggest that sleep quality might improve following levodopa–carbidopa intestinal gel (LCIG) infusion. The objective of this study was to evaluate the impact of LCIG infusion and subsequent oral medication changes on polysomnography (PSG) and sleep symptoms in advanced PD patients. Eleven PD patients underwent PSG at baseline and after 3.8 ± 1.2 months of LCIG treatment. LCIG infusion therapy was halted during PSG. Patients were assessed with the Unified-PD-rating-Scale and completed the PD-Sleep-Scale-version-2 (PDSS-2), the Epworth Sleepiness Scale and the RBD single question. Subjective sleep quality improved in all patients. PSG showed a reduction of the number of awakenings in sleep, a trend towards a lower apnea–hypopnea index and no change in sleep latency, total sleep time and sleep efficiency. There was a positive correlation between the number of awakenings and PDSS-2 scores for “difficulty staying asleep”, “muscle cramps of arms or legs” and “urge to move arms or legs”. Motor complications and activities of daily living improved with LCIG. Subjective sleep quality improved significantly and the PSG study showed a less fragmented sleep pattern in advanced PD patients treated with LCIG infusion.

KW - Excessive daytime sleepiness

KW - Levodopa–carbidopa intestinal gel infusion

KW - Parkinson’s disease

KW - Polysomnography

KW - Sleep disorders

UR - http://www.scopus.com/inward/record.url?scp=85018479588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018479588&partnerID=8YFLogxK

U2 - 10.1007/s00415-017-8491-2

DO - 10.1007/s00415-017-8491-2

M3 - Article

AN - SCOPUS:85018479588

VL - 264

SP - 1085

EP - 1090

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 6

ER -